Yue YangJingyang LiJu LiuLin LiuYongfu WangJiankang HuZhijun LiJieruo GuXiao ZhangZhengyu XiaoJunjie ZhengLin LiuZhanguo LiJames Cheng-Chung Wei2026-02-042026-02-042024-0110.1016/j.lanwpc.2023.100925https://scholars.csmu.edu.tw/handle/123456789/4937Safety and efficacy of peficitinib in Asian patients with rheumatoid arthritis who had an inadequate response or intolerance to methotrexate: results of a multicenter, randomized, double-blind, placebo-controlled phase 3 studyjournal-article